Fine numbers in Q1, but was likely the peak growth quarter. Growth now to decelerate, while capping margin expansion. We tweak TP to DKK 75 (70), reiterate SELL.

31 Jan 2024
Q1 was likely peak growth

Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Q1 was likely peak growth
Ambu A/S-B (AMBUB:CPH), 0 | Ambu A/S Class B (AMBU.B:CSE), 0 | Ambuja Cements Limited (500425:BOM), 0
- Published:
31 Jan 2024 -
Author:
ABGSC Healthcare Research | Morten Larsen -
Pages:
12 -
Fine numbers in Q1, but was likely the peak growth quarter. Growth now to decelerate, while capping margin expansion. We tweak TP to DKK 75 (70), reiterate SELL.